Once-weekly semaglutide versus placebo for the treatment of type 2 diabetes and chronic kidney disease in Denmark: A long-term cost-effectiveness analysis based on FLOW

Adding semaglutide to SoC was projected to be highly cost-effective over the long term in people with T2D and CKD in a Danish healthcare setting, based on patient characteristics and treatment effects from FLOW. Trial registration NCT03819153, first submitted on January 18, 2019.

Authors

Institutions

Publication Details

Journal
Cardiovascular Diabetology
Published
2025-12-20
DOI
https://doi.org/10.1186/s12933-025-03002-1
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Once-weekly semaglutide versus placebo for the treatment of type 2 diabetes and chronic kidney disease in Denmark: A long-term cost-effectiveness analysis based on FLOW

Tina Damgaard, Jyothi U. Menon, Rikke Alvilde Borg, Peter Rossing et al.
Cardiovascular Diabetology
Diabetes Treatment and Management
article

Once-weekly semaglutide versus placebo for the treatment of type 2 diabetes and chronic kidney disease in Denmark: A long-term cost-effectiveness analysis based on FLOW

Tina Damgaard, Jyothi U. Menon, Rikke Alvilde Borg, Peter Rossing, Juliette Cattin, Morten Lindhardt, Samuel J. P. Malkin, Barrie Chubb, Barnaby Hunt, Christian Klyver Tikkanen
article en

Abstract

Adding semaglutide to SoC was projected to be highly cost-effective over the long term in people with T2D and CKD in a Danish healthcare setting, based on patient characteristics and treatment effects from FLOW. Trial registration NCT03819153, first submitted on January 18, 2019.

Cardiovascular DiabetologyVol. 25(1)
University of Copenhagen (DK), Steno Diabetes Centers (DK), Novo Nordisk (Denmark) (DK), Copenhagen University Hospital (DK), Zealand University Hospital (DK), Department of Health (IE), Holbæk Sygehus (DK)
Good health and well-being
Openalex Percentile: Top 31%
Diabetes Treatment and Management
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.